“The marketplace is more volatile and violent than it has ever been” (Crest Advisory)
Bibliography: All Publications
Programming document 2020-22
The Programming Document 2020-22 translates the long-term priorities defined by the EMCDDA Strategy 2025 into short-term operational priorities
Drug-related hospital emergency presentations in Europe: update from the Euro-DEN Plus expert network
This report presents the latest findings on drug-related hospital emergencies from a network of sentinel hospitals across Europe. Almost 24 000 emergency presentations were recorded at 32 sentinel hospitals over the first 4 years of the project (EMCDDA)
Access to hepatitis c treatment and care among people who inject drugs: failing people most disproportionately affected
Accurate, high-quality data on hepatitis C continues to be a struggle for countries that are scaling up treatment access, expanding testing services, and developing national hepatitis plans (heoCoalition)
Trump Administration Seeks Increased Funding to Continue Curbing Drug Crisis
Trump Administration’s Fiscal Year (FY) 2021 National Drug Control Budget, which requests $35.7 billion for counter-drug efforts, an increase of $94 million from the previous year
National Drug Control Strategy 2020 (PDF)
A Report by the Office of National Drug Control Policy
Bloodborne viruses: Eye of the needle
‘Eye of the needle’ is a report on healthcare workers’ occupational exposures to bloodborne viruses such as hepatitis B, hepatitis C, and HIV (Public Health England)
Monitoring and evaluating changes in cannabis policies: insights from the Americas
This report provides an overview of the changes in cannabis policies in the Americas and the evidence emerging from evaluations of their impact (EMCDDA)
National intelligence network on drug health harms briefing
January 2020 (Public Health England)
Substance misuse treatment in secure settings: 2018 to 2019
Statistics for alcohol and drug misuse treatment in prisons and other secure settings from PHE’s national drug treatment monitoring system (NDTMS)
EU Drug Markets Report 2019
EMCDDA Director presents EU Drug Markets Report 2019 at European Parliament — ‘a clear wake-up call for policymakers’
Release of First-Ever National Clinical Guidelines on Substance Use Disorders among Older Canadians
Canadian healthcare providers now have the tools they need to better support the prevention, assessment and treatment of older adults at risk of, or living with, substance use disorders Canadian Coalition for Seniors’ Mental Health (CCSMH)
Drug-Related and Drug-Misuse Deaths 2008-2018
(Northern Ireland Statistics and Research Agency)
Investigating the association between an offender’s sex and ethnicity and the sentence imposed at the Crown Court for drug offences (PDF)
The Sentencing Council has conducted analysis of sentencing data to consider the association between an offender’s sex and ethnicity and the sentence imposed at the Crown Court for supply, possession with intent to supply and conspiracy to supply a controlled drug of classes A and B. In 2018, these offences accounted for around 12 per cent of all adult offenders sentenced at the Crown Court (Sentencing Council)
Left Behind: The Scale of Illegal Cannabis Use for Medicinal Intent in the UK
In this study, we used a cross-sectional national survey weighted to all adult groups in England, Wales and Scotland to identify this prevalence, and also to scale the monetary and personal costs of use (Centre for Medicinal Cannabis)
Seizures of drugs in England and Wales, financial year ending 2019 second edition
Contains figures for seizures of drugs made by local police forces and the UK Border Force (Home Office)
Misuse of fentanyl and fentanyl analogues
This report advises government on the number and nature of known fentanyl analogues, risk factors, pharmacology, toxic effects and misuse and associated harms (ACMD)
EMCDDA operating guidelines for the European Union Early Warning System on new psychoactive substances
These guidelines provide the rationale, steps, procedures, roles, and responsibilities for the operation of the EU Early Warning System (EMCDDA)
Monitoring the Future
Since 1975 the MTF survey has measured drug and alcohol use and related attitudes among adolescent students nationwide. Survey participants report their drug use behaviors across three time periods: lifetime, past year, and past month (NIH)
Shooting Up: infections among people who inject drugs in the UK
This Public Health England report describes the extent of infections among people who inject drugs (PWID) in the United Kingdom (Public Health England)
Misuse of illicit drugs and medicines: applying All Our Health
Evidence and guidance to help health professionals identify, prevent or reduce drug-related harm (Public Health England)
South Australia Drug Trends 2019
Key Findings from the Illicit Drug Reporting System (IDRS) Interviews (NDARC)
Opioids in the United States
The objective of this report is to provide timely information regarding the status of opioids including novel opioids and fentanyl analog prevalence, positivity, and discovery within the United States (NPS)
Trends in drug-related hospitalisations in Australia, 1999-2018
Each year, the Australian Institute of Health and Welfare (AIHW) makes available to Drug Trends in-depth data on drug-related hospitalisations in Australia from the National Hospital Morbidity Database (NDARC)
New South Wales Drug Trends 2019: Key Findings from the Illicit Drug Reporting system (IDRS) Interviews
The Illicit Drug Reporting System (IDRS) is an ongoing illicit drug monitoring system which has been conducted in all states and territories of Australia since 2000, and forms part of Drug Trends (NDARC)
National Drug-Related Deaths Index 2008 to 2017 data
This update presents figures from the National Drug-Related Deaths Index (NDRDI) on deaths due to poisoning (overdose) by alcohol and/or other drugs, and deaths among people who use drugs which are not due to poisoning (non-poisonings) for the period 2008-2017 (HRB Ireland)
Trends in drug-induced deaths in Australia, 1997-2018
Each year, the Australian Bureau of Statistics (ABS) makes available to Drug Trends in-depth data on drug-induced deaths in Australia. This year, we have produced a suite of products to summarise trends in drug-induced deaths in Australia from 1997 to 2018 (NDARC)
ACT Pill Testing Trial 2019 (PDF)
Program evaluation (Australian National University)
Needle Syringe Program National Minimum Data Collection Report 2019
The Needle Syringe Program National Minimum Data Collection (NSP NMDC) supports the National Strategies for blood borne and sexually transmissible infections and complements the annual Australian Needle Syringe Program Survey National Data Report (The Kirby Institute, Australia)
Seizures of drugs in England and Wales, financial year ending 2019
Contains figures for seizures of drugs made by local police forces and the UK Border Force (Home Office)
UN Common Position on drug policy – Consolidating system-wide coherence
This briefing paper reconstructs the long and troubled process that led to the adoption of this ground-breaking UN System Common Position (TNI)
Terrorism and drugs in Europe
Despite much speculation and conjecture over potential crossovers between terrorists and the drug trade in Europe, no study has examined the issue. This paper fills this gap by empirically examining such crossovers in the European Union between 2012 and 2017 (EMCDDA)
Drug seizures and arrests in Northern Ireland, period ending 30 September 2019
Six-monthly update of class A, B and C drug seizure incidents and arrests by PSNI (Police Service of Northern Ireland)
Highlights from the EU Drug Markets Report for policy and practice
This short publication presents the main highlights from the EU Drug Markets Report 2019, targeting policy and practice (EMCDDA)
Global State of Harm Reduction: 2019 updates
The 2019 update to Harm Reduction International’s flagship publication, the Global State of Harm Reduction, includes updates to some of the key data in the report, including the opening of new drug consumption rooms, availability of needle and syringe programs, and references to harm reduction in national policy documents, among many other things
Statistics on Drug Misuse, England, 2019
This publication provides a range of information relating to drug misuse drawn from a variety of sources. Topics covered are drug related hospital admissions, deaths related to poisoning by drug misuse, drug use prevalence amongst adults and children, drug dependency, and drug seizures (NHS Digital)
Scottish Schools Adolescent Lifestyle and Substance Use Survey (SALSUS): national overview 2018
Overview of findings on alcohol, drug use and smoking from the 2018 wave of the Scottish Schools Adolescent Lifestyle and Substance Use Survey – SALSUS (Scottish Government)
Substance misuse treatment for young people: statistics 2018 to 2019
Alcohol and drug treatment data for under-18s from PHE’s National Drug Treatment Monitoring System – NDTMS (Public Health England)
Using open-source information to improve the European drug monitoring system
This paper explains the methodology developed by the EMCDDA for open-source information monitoring in the area of drug markets. Initially designed to support the work of the EU Early Warning System in 2016, the technique has recently been expanded to cover open-source information through a pilot project focusing on data on heroin and cocaine seizures of 100 kg or more for the European market between April 2017 and March 2018 (EMCDDA)
Drug precursor developments in the European Union
This paper describes the significant developments that have occurred in the last 5 to 10 years in the field of drug precursors related to synthetic stimulant drugs produced in the EU (EMCDDA)
- « Previous Page
- 1
- …
- 12
- 13
- 14
- 15
- 16
- …
- 49
- Next Page »
